Company Encyclopedia
View More
name
First Trust Nasdaq Lux Digital Health Solutions ETF
EKG.US
News
View More

DexCom Faces Class Action Lawsuit Over Alleged Securities Fraud

A class action lawsuit has been filed against DexCom Inc. for allegedly making false and misleading statements about its glucose monitoring products, the G6 and G7. The lawsuit claims unauthorized design changes were made without FDA approval, making the products less reliable and posing health risks. The litigation covers investors who suffered losses between January 8, 2024, and September 17, 2025.

Reuters·
US
DXCM
-0.12%
Reuters·
US
DXCM
-0.12%

DAVENPORT & Co LLC Increases Position in DexCom, Inc. $DXCM

DAVENPORT & Co LLC lifted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 21.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC.

Market Beat·
US
DXCM
-0.12%
Market Beat·
US
DXCM
-0.12%

Class Action Initiated by Pomerantz LLP Concerning DexCom, Inc. – DXCM

Pomerantz LLP has filed a class action lawsuit against DexCom, Inc. and certain officers, alleging violations of federal securities laws. The lawsuit claims DexCom made unauthorized design changes to its G6 and G7 devices, leading to reliability issues and health risks. The FDA issued a warning letter, causing DexCom's stock price to drop. Investors have until December 26, 2025, to seek appointment as Lead Plaintiff.

Acceswire·
US
DXCM
-0.12%
Acceswire·
US
DXCM
-0.12%

Hunter Perkins Capital Management LLC Takes Position in Align Technology, Inc. $ALGN

Hunter Perkins Capital Management LLC acquired 9,075 shares of Align Technology, Inc. valued at approximately $1,136,000 during the 3rd quarter. Align Technology, a medical equipment provider, reported a quarterly EPS of $2.61, surpassing estimates. The company's stock has an average rating of 'Hold' with a target price of $172.18. Align Technology's market cap is $11.22 billion, with a P/E ratio of 30.32. Institutional investors own 88.43% of the stock.

Market Beat·
US
ALGN
-0.29%
Market Beat·
US
ALGN
-0.29%

Swedbank AB Sells 14,268 Shares of Align Technology, Inc. $ALGN

Swedbank AB reduced its stake in Align Technology, Inc. by 3.4% in the third quarter, selling 14,268 shares. The fund now owns 406,459 shares, valued at $50,897,000. Align Technology's recent earnings beat expectations, with a reported EPS of $2.61. Analysts have mixed ratings on the stock, with a consensus rating of 'Hold' and a target price of $172.18.

Market Beat·
US
ALGN
-0.29%
Market Beat·
US
ALGN
-0.29%
© 2025 Longbridge｜Disclaimer